| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3961899 | Journal of Minimally Invasive Gynecology | 2014 | 46 Pages |
Abstract
Essure hysteroscopic sterilization has been US Food and Drug Administration-approved in the United States since 2002. Complications associated with the Essure device include improper placement (malpositioning), unintended pregnancy, pain, infection, and nickel allergy. The rarity of complications, compounded by underreporting, makes it difficult to determine best practices insofar as management. This systematic review synthesizes the national and global experience with management of Essure-related complications and suggests treatment options when data allow.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Marisa R. MD, Mark W. MD, Howard T. MD,